BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36890164)

  • 1. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study.
    Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H
    Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
    Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
    Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.
    Zuo Y; Ye L; Chen F; Shen Y; Lu X; Wang G; Shu X
    Front Immunol; 2022; 13():845988. PubMed ID: 35320936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression prediction in idiopathic inflammatory myopathy-associated interstitial lung disease: a combination of initial high attenuation areas and anti-melanoma differentiation-associated gene 5-positive.
    Fang X; Zou L; Zhao H; Liu B
    Clin Exp Rheumatol; 2024 Feb; 42(2):253-261. PubMed ID: 38293996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease.
    Hannah JR; Law HE; Gordon T; Rooney M; Buazon A; Adas M; Nagra D; Stovin C; Galloway J; Gordon PA
    J Rheumatol; 2023 Mar; 50(3):373-383. PubMed ID: 36379584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.
    Shao C; Xia N; Zhen Y; Zhang X; Yan N; Guo Q
    Front Immunol; 2024; 15():1404828. PubMed ID: 38745647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
    Bai Z; Shen G; Dong L
    Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
    Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
    Front Immunol; 2022; 13():879266. PubMed ID: 35603153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis.
    He X; Ji J; Chen X; Luo Z; Fang S; Yan H; Guo L
    Semin Arthritis Rheum; 2024 Feb; 64():152350. PubMed ID: 38086199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of peripheral blood markers in patients with myositis-associated interstitial lung diseases.
    Jin YZ; Xie MS; Yang C; Wu RL; Zhou YB; Li XM
    Scand J Rheumatol; 2021 May; 50(3):218-226. PubMed ID: 33475038
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease.
    Gui X; Shenyun S; Ding H; Wang R; Tong J; Yu M; Zhao T; Ma M; Ding J; Xin X; Qiu Y; Qiu X; Zhang Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
    Rheumatology (Oxford); 2022 Nov; 61(11):4570-4578. PubMed ID: 35148366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
    Chen X; Zhang L; Jin Q; Lu X; Lei J; Peng Q; Wang G; Ge Y
    Front Immunol; 2022; 13():987841. PubMed ID: 36110863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review.
    Teel A; Lu J; Park J; Singh N; Basharat P
    Semin Arthritis Rheum; 2022 Dec; 57():152088. PubMed ID: 36116345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies.
    Lan JL; Chang SH; Tsay GJ; Chen DY; Chao YH; Li JP
    BMC Immunol; 2023 Sep; 24(1):33. PubMed ID: 37752437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
    Huang HL; Lin WC; Lin PY; Weng MY; Sun YT
    Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on Myositis-Specific Autoantibodies: A Single Cohort Study.
    Jiang W; Shi J; Yang H; Tian X; Yang H; Chen Q; Zhang L; Peng Q; Wang G; Lu X
    Arthritis Care Res (Hoboken); 2023 May; 75(5):1175-1182. PubMed ID: 35921214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.